
Health Catalyst, Inc: updates and filings
Price
$1.29
November 19, 2026Market cap $95M
What Ploutos Investor adds for Health Catalyst
Part of Ploutos Investor, €9.99 a month
- The full history: 9 fiscal years, from 2017
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 5, 2026next Feb 5, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
September 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Results of operationsForm8-K
- Sep 14, 2026Shares registered for employeesFormS-8
- Sep 14, 2026Officer or director change, Regulation FD disclosureForm8-K
- Sep 8, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Sep 8, 2026Officer or director change, Regulation FD disclosureForm8-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Material agreement ended, acquisition or disposal of assets, results of operations, Regulation FD disclosureForm8-K
- Jul 28, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 21, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 20, 2026Shareholder voteForm8-K
- Jun 22, 2026Over-5% holder statement (active)FormSCHEDULE 13D
- Jun 8, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Jun 4, 2026Material agreement entered, Regulation FD disclosureForm8-K
- Jun 3, 2026Additional annual meeting materialFormDEFA14A
- Jun 3, 2026Annual meeting proxy statementFormDEF 14A
- May 19, 2026Preliminary proxy statementFormPRE 14A
- May 15, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 11, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 11, 2026Results of operationsForm8-K
- Apr 30, 2026Annual report (amendment)for the period to Dec 31, 2025Form10-K/A
- Apr 30, 2026Officer or director change, Regulation FD disclosureForm8-K
- Apr 27, 2026Officer or director change, other material eventsForm8-K
- Apr 3, 2026Officer or director changeForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Results of operations | Document |
| Sep 14, 2026 | S-8 | Shares registered for employees | Document |
| Sep 14, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Sep 8, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Sep 8, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Material agreement ended, acquisition or disposal of assets, results of operations, Regulation FD disclosure | Document |
| Jul 28, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 21, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 20, 2026 | 8-K | Shareholder vote | Document |
| Jun 22, 2026 | SCHEDULE 13D | Over-5% holder statement (active) | Document |
| Jun 8, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Jun 4, 2026 | 8-K | Material agreement entered, Regulation FD disclosure | Document |
| Jun 3, 2026 | DEFA14A | Additional annual meeting material | Document |
| Jun 3, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| May 19, 2026 | PRE 14A | Preliminary proxy statement | Document |
| May 15, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 11, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 11, 2026 | 8-K | Results of operations | Document |
| Apr 30, 2026 | 10-K/A | Annual report (amendment)for the period to Dec 31, 2025 | Document |
| Apr 30, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Apr 27, 2026 | 8-K | Officer or director change, other material events | Document |
| Apr 3, 2026 | 8-K | Officer or director change | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Mar 27, 2015.
The full analysis
What do Health Catalyst's filings show?
The filings are where every one of Health Catalyst's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.